QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文 BLOOD, 2018, 卷号: 132 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China 期刊论文 2018, 卷号: 24, 页码: 5258-5270 作者:  Zhang, Xiaohui;  Hu, Jiong;  Hu, Yu;  Huang, He;  Jin, Jie 收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03 Antifungal Agents  Fruiting Bodies  Fungal  Hematologic Neoplasms   Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study 期刊论文 2018, 卷号: 48, 期号: 6, 页码: 713-720 作者:  Li, Yan;  Liu, Mingjuan;  Zhai, Bing;  Zhao, Xiaoli;  Wang, Lijun 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 primary antifungal prophylaxis  invasive fungal disease  haematological malignancies  risk factors   Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文 2018, 卷号: 132 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文 BLOOD, 2018-11-29 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03